Search clinical trials for: Fulvestrant
Total 446 results
-
Seagen Inc.Active, not recruitingUrologic Neoplasms | Uterine Cervical Neoplasms | Uterine Neoplasms | Carcinoma, Non-Small-Cell Lung | Biliary Tract Neoplasms | HER2 Mutations Breast NeoplasmsUnited States, United Kingdom, Spain, Korea, Republic of, Italy, Belgium, Germany, Japan, Netherlands, Poland
-
Georgetown UniversityUniversity of Chicago; Thomas Jefferson UniversityCompletedHormone Receptor Positive HER-2 Negative Breast CancerUnited States
-
Kyowa Kirin Co., Ltd.CompletedMultiple Myeloma and Malignant LymphomaJapan
-
Avenzo Therapeutics, Inc.Recruiting
-
UNICANCERPfizerActive, not recruitingMetastatic Breast CancerFrance
-
Dr. Reddy's Laboratories SASRecruitingBreast Neoplasm FemaleColombia
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Brigham... and other collaboratorsCompletedBreast CancerUnited States
-
AstraZenecaCompletedEndometrial CarcinomaGermany
-
Sermonix Pharmaceuticals Inc.Linical Accelovance GroupActive, not recruitingLocally Advanced or Metastatic Breast CancerUnited States, Canada, Israel
-
Consorzio OncotechClinical Research Technology S.r.l.UnknownMetastatic Breast CancerItaly
-
Regina Elena Cancer InstituteAstraZenecaUnknown
-
Frederic AmantKom Op Tegen Kanker; FWO Research Fund FlandersRecruitingEndometrial Cancer | Endometrial Stromal Sarcoma | Sex Cord Stromal Tumor | Adenosarcoma of Uterus | Leiomyosarcoma Uterus | Serous Ovarian TumorBelgium
-
AstraZenecaCompletedMetastatic Breast Cancer | Locally Advanced orKorea, Republic of
-
Fudan UniversityUnknown
-
National Cancer Institute (NCI)CompletedStage IV Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-positive Breast CancerUnited States
-
The Affiliated Hospital of Qingdao UniversityNot yet recruitingNeoplasms | Breast Cancer | Breast DiseasesChina
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityJiangsu HengRui Medicine Co., Ltd.RecruitingMetastatic Breast CancerChina
-
PfizerRecruitingBreast Cancer | Solid TumorsChina, United States, Bulgaria, Spain, Brazil, Czechia, Argentina, South Africa, Mexico
-
Novartis PharmaceuticalsRecruiting
-
AstraZenecaActive, not recruitingAdvanced ER-Positive HER2-Negative Breast CancerUnited States, Italy, Spain, Belgium, Poland, Canada, Germany, Korea, Republic of, Russian Federation, France, Israel, Hungary, Portugal, United Kingdom, Georgia, Ukraine
-
Novartis PharmaceuticalsCompletedEstrogen Receptor Positive Breast Cancer | Advanced Solid Tumors With an Alteration of the PIK3CA GeneUnited States, Netherlands, Spain, Germany, United Kingdom
-
Masonic Cancer Center, University of MinnesotaCompletedOvarian CancerUnited States
-
Hellenic Oncology Research GroupCompleted
-
AstraZenecaDendrix - Scientific Information ArchitectureCompleted
-
Liaoning Tumor Hospital & InstituteRecruiting
-
AstraZenecaActive, not recruitingBreast CancerBelgium, Spain, Italy, United States, Brazil, Czechia, Russian Federation, Chile, Slovakia, Hungary, India, Ukraine, Venezuela, Colombia, Poland, Malta, Mexico
-
University Health Network, TorontoActive, not recruitingBreast Cancer | Advanced Solid CancersCanada
-
GlaxoSmithKlineTerminatedNeoplasmsUnited States, Korea, Republic of, Canada, Spain, Australia, United Kingdom, France
-
Velindre NHS TrustAstraZeneca; Cardiff and Vale University Health Board; Covance; Cenduit LLCActive, not recruitingEstrogen Receptor Positive Breast CancerUnited Kingdom
-
Mayo ClinicAstraZeneca; National Institutes of Health (NIH)CompletedHealthyUnited States
-
Sarah K. Lynam MDBayerRecruitingOvarian Cancer | Serous Ovarian CancerUnited States
-
Novartis PharmaceuticalsRecruitingHormone Receptor Positive HER2 Negative Breast Cancer With a PIK3CA MutationSpain, Italy, Austria
-
Beth Israel Deaconess Medical CenterUniversity of Colorado, Denver; Massachusetts General Hospital; Dana-Farber Cancer... and other collaboratorsActive, not recruiting
-
Memorial Sloan Kettering Cancer CenterEli Lilly and CompanyActive, not recruitingAdenocarcinoma of EndometriumUnited States
-
Laekna LLCActive, not recruitingBreast CancerUnited States, China
-
AstraZenecaCompletedBreast NeoplasmsBelgium, Switzerland
-
Canadian Cancer Trials GroupPfizerCompleted
-
AstraZenecaCompletedPuberty, Precocious | McCune-Albright SyndromeItaly, United States, Germany, France, Russian Federation, United Kingdom
-
Memorial Sloan Kettering Cancer CenterCompletedBreast Cancer | Metastatic Breast Cancer | Breast Cancer Stage IV | Solid Carcinoma | HER2-negative Breast Cancer | MEK1 Gene Mutation | MEK2 Gene MutationUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedBreast Cancer | Prostate Cancer | Advanced Solid TumorsUnited States
-
Eli Lilly and CompanyCompleted
-
Hoffmann-La RocheTerminatedEstrogen Receptor-positive (ER+)/Human Epidermal Growth Factor Receptor (HER2)-Negative Locally Advanced or Metastatic Breast CancerCanada, United States, United Kingdom, Australia, Germany
-
University of PennsylvaniaCompletedPulmonary Arterial HypertensionUnited States
-
Fresenius KabiCompleted
-
Isabel BlancasCompletedMalignant Neoplasm of Breast Stage IVSpain
-
Carrick Therapeutics LimitedPfizerRecruitingBreast Cancer | Metastatic Breast Cancer | Locally Advanced Breast CancerSpain, United States, Turkey, Hungary
-
Novartis PharmaceuticalsActive, not recruiting
-
Dana-Farber Cancer InstitutePuma Biotechnology, Inc.Terminated
-
Henan Cancer HospitalActive, not recruitingMetastatic Breast CancerChina
-
SanofiTerminatedBreast NeoplasmsFrance, Italy, Spain